Doerthe Eckert

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Ankylosing Spondylitis

Extracorporeal Membrane Oxygenation

Electronic Health Record

Top Venues

Clinical and translational science

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis. Clinical and translational science 17 (2) (2024)
Sumit Bhatnagar, Louisa Schlachter, Doerthe Eckert, Sven Stodtmann, Wei Liu, Ana P Lacerda, Mohamed-Eslam F Mohamed
Pharmacokinetics and Exposure-Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease. Clinical pharmacology and therapeutics (2024)
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of apadacitinib in patients with axial Spondyloarthritis. Clinical and translational science 17 (2) (2024)
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of apadacitinib in patients with axial Spondyloarthritis. Clinical and translational science 17 (2) (2024)
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis. Clinical and translational science 17 (2) (2024)
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis. Clinical and translational science 17 (2) (2024)